$CLB News

Core Laboratories Inc. (CLB) Q1 2026 Earnings Call Transcript

Core Laboratories Sees Q2 GAAP EPS $0.06-$0.12 vs $0.09 Est; Sees Sales $123.000M-$131.000M vs $127.900M Est

Core Laboratories Q1 Adj. EPS $0.06 Misses $0.11 Estimate, Sales $121.797M Miss $124.935M Estimate

Core Laboratories: Profit Margins Are Too Small To Get Excited About

Core Laboratories Sees Q1 Adj EPS $0.05-$0.07 vs $0.14 Est; Lowers Q1 Sales Guidance from $124.000M-$130.000M to $119.000M-$123.000M vs $128.290M Est

Core Laboratories Inc. (CLB) Q4 2025 Earnings Call Transcript

Core Laboratories Sees Q1 GAAP EPS $0.11-$0.15 vs $0.15 Est; Sees Sales $124.000M-$130.000M vs $128.290M Est

Core Laboratories Q4 Adj. EPS $0.21 Beats $0.19 Estimate, Sales $138.255M Beat $131.100M Estimate

RPC (RES) Lags Q4 Earnings Estimates

Investors in Core Laboratories (NYSE:CLB) have unfortunately lost 47% over the last five years

Core Laboratories: Providing The Technology To Replace Tier-1 Oil Inventory

CORE LABORATORIES ANNOUNCES TIMING OF FOURTH QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

Calculating The Fair Value Of Core Laboratories Inc. (NYSE:CLB)

P/E Ratio Insights for Core Laboratories

Core Laboratories (CLB) Down 15.6% Since Last Earnings Report: Can It Rebound?

Core Laboratories Inc.'s (NYSE:CLB) Stock Is Going Strong: Is the Market Following Fundamentals?

Core Laboratories Inc (CLB) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ...

Core Laboratories (CLB) Price Target Increased by 11.51% to 15.64

Core Laboratories (CLB) Skyrockets After Beating Estimates in Q3

Core Laboratories (CLB) Margin Gains Reinforce Bullish Narrative Despite Slowing Revenue Growth